Biden Administration Rescinds Trump Administration Insulin …
网页2021年10月26日 · One of the final healthcare actions made by the Trump Administration has been rescinded by the Biden Administration. On December 23, 2020, the Trump Administration finalized a rule that directed the Department of Health and Human Services (HHS) to take action to require that federally qualified health centers (FQHCs) make …
California Passes Senate Bill 1419 Law to Revise ... - Policy
网页2022年10月6日 · On September 30th Governor Newsome signed Senate Bill 1419, legislation sponsored by the California Medical Association and focused on providing physicians the opportunity to respect patient privacy and wishes when releasing their protected health information.. While the 21 st Century Cures Act Information Blocking …
PhRMA Announces Updated Code on Interactions with Health …
网页On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released its updated Code on Interactions with Health Care Professionals, a voluntary code of ethics that applies to pharmaceutical company interactions with United States health care professionals. As a member of the International Federation of Pharmaceutical …
CMS Updates Guidance on Sunshine Act Reporting Thresholds for …
网页2021年1月25日 · At the end of 2020, the Centers for Medicare and Medicaid Services (CMS) issued updated guidance on the thresholds that require an Applicable Manufacturer or Group Purchasing Organization to report under the Sunshine Act. Under the new guidance, if an Applicable Manufacturer or Group Purchasing Organization spends $11.05 or more …
Avoiding Medicare Fraud & Abuse: A Roadmap for Physicians
网页2015年7月31日 · The Centers for Medicare and Medicaid Services (CMS) published a “roadmap for physicians” to submit proper claims for reimbursement. The guide, which walks through pertinent fraud and abuse laws and certain best practices for physicians, in turn provides manufacturers a helpful, convenient compliance tool as well.
Institute of Medicine Report – The Future of Nursing: Leading …
网页2011年2月17日 · As the current debate surrounding the Affordable Care Act (ACA) continues in Congress, a number of strengths and weaknesses of the legislation are being emphasized. One specific issue is how the American …
ACO Update: What Challenges Lie Ahead? – Policy & Medicine
网页2014年9月16日 · Despite these growing numbers, two interesting articles were published describing the difficulties facing ACO growth. First, Dr. Robert Pearl, M.D., described the four major challenges facing ACOs: (1) Perverse Payment Model; (2) Wrong-Sized Medical Staff; (3) Technology Platform Incompatibility; and (4) Lack of Physician Leadership and ...
Prescription Copays More Expensive Than Full Price?
网页2018年9月7日 · A study published this year by the University of Southern California’s Schaeffer Center for Health Policy and Economics, Overpaying for Prescription Drugs: The Copay Clawback Phenomenon, found that insurance copays can occasionally be higher than the cost of the actual drug.. A PBS article brought the study to a brighter light, citing …
Amgen Settlement and Corporate Integrity Agreement
网页2013年2月19日 · Amgen, a biotechnology company, agreed to pay $762 million—the single largest criminal and civil False Claims Act settlement involving a biotechnology company in U.S. history, according to the announcement. Amgen entered a guilty plea before U.S. District Judge Sterling Johnson of the Eastern District of New York to a criminal …
FDA Issues Draft Guidance on Proprietary Names
网页2021年2月2日 · The U.S. Food and Drug Administration (FDA) issued a pair of draft guidance documents aimed at guiding the selection of proprietary names for prescription and non-prescription drugs. The best practices set forth in the guidances are designed “to help minimize proprietary name-related medication errors and otherwise avoid adoption of ...
跳至内容